References
- StulpRPHerkertJCKarrenbeldAMolBVosYJSijmonsRHThyroid cancer in patient with germline MSH2 mutation. Case report and review of Lynch syndrome expanding tumor spectrumHered Cancer Clin Pract20086152119706203
- BroaddusRRLynchPMLuKHLuthraRMichelsonSJUnusual tumors associated with the hereditary nonpolyposis colorectal cancer syndromeModern Pathol200417981989
- LiptonLRJohnsonVCummingsCRefining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinicJ Clin Oncol2004224934494315611508
- LimSMChangHYoonMJA multicentre phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesAnn Oncol2013243089309424050953
- FaginJAMitsiadesNMolecular pathology of thyroid cancer: diagnostic and clinical implicationsBest Pract Res Clin Endocrinol Metab20082295596919041825
- NagasakaTRheesJKloorMGebertJNaomotoYBolandRGoelASomatic hypermethylation of MSH2 is a frequent event in Lynch syndrome colorectal cancersCancer Res2010703098310820388775
- SistiATassinariJNisiGSynchronous and metachronous malignancies after malignant struma ovarii in the SEER databaseIn Vivo20163071371627566096
- SistiGDi TommasoMCommentary on “Study of prevalence of autoimmune thyroid disease in women with breast cancer”Endocr Pract20162211411626595512
- LiuLShiJMaoFWeiJFuDZhangJSynchronous primary cancers of the thyroid and breast: a case report and review of the literatureOncol Lett2015935135425435991
- ShiaJImmunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndromeJ Mol Diagn20081029330018556767